Factor VIII accelerates proteolytic cleavage of von Willebrand factor by ADAMTS13

Wenjing Cao1, Sriram Krishnaswamy, Rodney M Camire

  • 1Departments of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA 19104, USA.

Insights

Coagulation factor VIII (FVIII) significantly accelerates von Willebrand factor (VWF) processing by ADAMTS13 under shear stress. This interaction is crucial for regulating VWF cleavage and maintaining normal hemostasis.

Area of Science:

  • Biochemistry
  • Hematology
  • Molecular Biology

Background:

  • Proteolytic processing of von Willebrand factor (VWF) by ADAMTS13 is essential for hemostasis.
  • ADAMTS13 cleavage of VWF is inefficient in vitro, even under high shear stress, often requiring denaturants.

Purpose of the Study:

  • To investigate the role of coagulation factor VIII (FVIII) in modulating VWF cleavage by ADAMTS13.
  • To elucidate the mechanism and conditions under which FVIII influences VWF processing.

Main Methods:

  • In vitro assays measuring VWF cleavage by ADAMTS13 under controlled shear stress.
  • Multimer analysis to assess VWF integrity and processing.
  • Use of modified FVIII derivatives to identify key functional domains.

Main Results:

  • FVIII accelerates VWF cleavage by ADAMTS13 approximately 10-fold under physiological conditions (shear stress, pH, ionic strength).
  • FVIII preferentially enhances the cleavage of high-molecular-weight VWF multimers.
  • The rate enhancement is dependent on the high-affinity interaction between FVIII and VWF, specifically involving the FVIII acidic region a3.

Conclusions:

  • FVIII plays a critical regulatory role in the proteolytic processing of VWF by ADAMTS13 under shear stress.
  • The interaction between FVIII and VWF is key to this regulatory function, impacting VWF multimer structure and hemostasis.
  • These findings reveal a novel function for FVIII in VWF processing beyond its role as a coagulation factor.

Related Concept Videos

Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Coagulation01:09

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...